Tempest Therapeutics, Inc.

TPST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 14, 2026 10-Q
8-K May 14, 2026 8-K
8-K May 6, 2026 8-K
424B3 Apr 10, 2026 424B3
424B3 Apr 10, 2026 424B3
EFFECT Apr 9, 2026
CORRESP Apr 8, 2026
UPLOAD Apr 7, 2026
EFFECT Apr 3, 2026
D Apr 3, 2026
4 Apr 2, 2026
4 Apr 2, 2026
SCHEDULE 13D/A Apr 2, 2026
S-3 Apr 2, 2026 S-3
CORRESP Apr 1, 2026
UPLOAD Apr 1, 2026
S-8 POS Mar 31, 2026 S-8 POS
S-3 Mar 30, 2026 S-3
S-8 Mar 30, 2026 S-8
10-K Mar 30, 2026 10-K
8-K Mar 30, 2026 8-K
SCHEDULE 13D/A Mar 25, 2026
4 Mar 25, 2026
8-K Mar 23, 2026 8-K
8-K Feb 25, 2026 8-K
← Newer Page 3 of 42 · 1047 filings Older →